PENTA-SULINDAC 200 MG
SULINDAC : 200 MG · DIN 02239164 · PENTAPHARM LTD.
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is PENTA-SULINDAC?
PENTA-SULINDAC 200 MG contains SULINDAC : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02239164, held by PENTAPHARM LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 05-Apr-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02239164 |
|---|---|
| Brand name | PENTA-SULINDAC |
| Generic / active ingredient | SULINDAC : 200 MG |
| Manufacturer | PENTAPHARM LTD. |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M01AB02 SULINDAC |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 05-Apr-2018 |
What can be used instead?
Other Canadian products sharing ATC code M01AB02 SULINDAC. 2 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-SULINDAC | 150 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00745588 |
| TEVA-SULINDAC | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00745596 |
| APO-SULIN TAB 150MG | 150 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00778354 |
| APO-SULIN TAB 200MG | 200 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00778362 |
| CLINORIL TAB 150MG | 150 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00456888 |
| CLINORIL TAB 200MG | 200 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00432369 |
| NU-SULINDAC TAB 150MG | 150 MG | TABLET | NU-PHARM INC | CANCELLED POST MARKET | DIN 02042576 |
| NU-SULINDAC TAB 200MG | 200 MG | TABLET | NU-PHARM INC | CANCELLED POST MARKET | DIN 02042584 |
| PENTA-SULINDAC | 150 MG | TABLET | PENTAPHARM LTD. | CANCELLED (UNRETURNED ANNUAL) | DIN 02239163 |
| SULINDAC-150 TAB 150MG | 150 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00808628 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled (unreturned annual) in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.